Business Context and Reporting Period
Company: Intelligent Bio Solutions Inc. (INBS)
Filing Type: Form 8-K (Current Report)
Date of Report: September 20, 2025
Reporting Period: Event date of September 20, 2025
The Company is an emerging growth company incorporated in Delaware. This filing reports a corporate action regarding the extension of the termination date for outstanding Series H-1 Common Stock Purchase Warrants.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on a specific corporate event regarding warrant terms.
Material Changes
- Warrant Extension: The Board of Directors approved extending the termination date of the Series H-1 Warrants from September 27, 2025, to March 27, 2026.
- Outstanding Volume: There are currently 1,034,213 Series H-1 Warrants outstanding held by six warrant holders.
- Terms: Exercise prices and other terms of the warrants remain unchanged.
- Consideration: The Company did not receive any consideration for this extension.
Guidance, Outlook, and Risks
Management Commentary: The extension was executed with the consent of all six warrant holders. No other agreements or understandings exist between the Company and the warrant holders regarding this extension.
Risks and Contingencies: The filing does not disclose new material risks or contingencies beyond the standard terms of the amended warrant agreement.
Guidance: No financial guidance or forward-looking outlook is provided in this filing.
Investor Verification Checklist
- Verify the current exercise price of the Series H-1 Warrants, as it remains unchanged but is not listed in this summary.
- Confirm the total number of shares underlying the 1,034,213 outstanding warrants.
- Review the full text of the Amended Series H-1 Warrant (Exhibit 4.1) for any non-standard provisions.
- Monitor the Company's cash position to assess its ability to manage potential dilution if warrants are exercised by the new March 27, 2026 deadline.